昼夜节律,荷尔蒙节律和睡眠节律:对癌症进展的影响,对治疗的影响
Annemarie D Jagielo1,2, Catherine Benedict2, David Spiegel2
1PGSP-Stanford Psy.D. Consortium, Palo Alto University, Palo Alto, CA, United States.
Frontiers in oncology
|September 25, 2023
概括
癌症患者经常经历昼夜,激素和睡眠节律的破坏. 通过治疗这些干扰,如调化学疗法,可以改善睡眠和癌症的结果.
科学领域:
- 在瘤学瘤学.
- 睡眠医学 睡眠医学
- 时间生物学 时间生物学
背景情况:
- 循环节,荷尔蒙和睡眠节律的障碍在癌症患者中很常见.
- 这些干扰影响了整个癌症护理连续.
- 了解这些节奏对于患者的福祉和治疗疗效至关重要.
研究的目的:
- 对癌症患者的昼夜节律,荷尔蒙和睡眠节律的现有文献进行审查.
- 专注于昼夜干扰与生理,心理和疾病进展的联系.
- 探索与癌症相关的节律障碍的时间调节治疗策略.
主要方法:
- 对瘤学中昼夜节律,荷尔蒙节律和睡眠节律的研究进行系统文献综述.
- 对研究分析,将昼夜干扰与患者的结果联系起来.
- 对时间调制疗法的证据评估.
主要成果:
- 循环节律的扰乱,主观和客观,与癌症患者的心理健康状况不佳和不良疾病结果有关.
- 时间调节化疗,光疗,对失眠的认知行为疗法和体育活动显示出有前途.
- 这些干预措施可以改善睡眠质量,在某些情况下,改善癌症的结果.
结论:
- 循环节律障碍是瘤学中的一个重要问题,具有明显的负面影响.
- 时间调节治疗提供了一种可行的方法来缓解这些干扰.
- 对时代生物学的进一步研究可以优化癌症护理和患者康复.
相关概念视频
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
81
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
81
Management of Insomnia
274
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
274
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K


